Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Warn-Cramer

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Thrombosis Research|October 1, 1987
Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor)B J Warn-Cramer, S L Maki, A Zivelin, et al.
The Journal of Cell Biology|August 22, 2001
v-Src phosphorylation of connexin 43 on Tyr247 and Tyr265 disrupts gap junctional communicationR Lin, B J Warn-Cramer, W E Kurata, et al.
Cell Communication & Adhesion|June 18, 2002
v-Src-mediated phosphorylation of connexin43 on tyrosine disrupts gap junctional communication in mammalian cellsR Lin, B J Warn-Cramer, W E Kurata, et al.
The Journal of Clinical Investigation|January 1, 1985
Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic siteP Usharani, B J Warn-Cramer, C K Kasper, et al.
Blood|July 1, 1989
Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variablesT A Warr, B J Warn-Cramer, L V Rao, et al.
Thrombosis and Haemostasis|December 22, 1988
Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibitionB J Warn-Cramer, L V Rao, S L Maki, et al.
Journal of Cell Science|May 12, 1998
Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinaseP D Lampe, W E Kurata, B J Warn-Cramer, et al.
The Journal of Biological Chemistry|May 16, 1998
Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinaseB J Warn-Cramer, G T Cottrell, J M Burt, et al.
The Biochemical Journal|January 1, 1990
Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteinsS G Spitzer, B J Warn-Cramer, C K Kasper, et al.
Blood|September 15, 1991
Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reactionP M Sandset, B J Warn-Cramer, S L Maki, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Thrombosis Research|October 1, 1987
Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor)B J Warn-Cramer, S L Maki, A Zivelin, et al.
The Journal of Cell Biology|August 22, 2001
v-Src phosphorylation of connexin 43 on Tyr247 and Tyr265 disrupts gap junctional communicationR Lin, B J Warn-Cramer, W E Kurata, et al.
Cell Communication & Adhesion|June 18, 2002
v-Src-mediated phosphorylation of connexin43 on tyrosine disrupts gap junctional communication in mammalian cellsR Lin, B J Warn-Cramer, W E Kurata, et al.
The Journal of Clinical Investigation|January 1, 1985
Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic siteP Usharani, B J Warn-Cramer, C K Kasper, et al.
Blood|July 1, 1989
Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variablesT A Warr, B J Warn-Cramer, L V Rao, et al.
Thrombosis and Haemostasis|December 22, 1988
Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibitionB J Warn-Cramer, L V Rao, S L Maki, et al.
Journal of Cell Science|May 12, 1998
Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinaseP D Lampe, W E Kurata, B J Warn-Cramer, et al.
The Journal of Biological Chemistry|May 16, 1998
Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinaseB J Warn-Cramer, G T Cottrell, J M Burt, et al.
The Biochemical Journal|January 1, 1990
Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteinsS G Spitzer, B J Warn-Cramer, C K Kasper, et al.
Blood|September 15, 1991
Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reactionP M Sandset, B J Warn-Cramer, S L Maki, et al.
Pageof 3